DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Karran E, Hardy J.
A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease.
Ann Neurol 2014;
76 (02) 185-205
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.